{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T10:06:31Z","timestamp":1774951591677,"version":"3.50.1"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess, in patients with chronic hypoparathyroidism, the relative contribution to serum calcium value of intestinal calcium absorption, renal tubular calcium reabsorption, and net bone calcium release, altered by parathyroid hormone (PTH) and calcitriol deficiency.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective, single-center collection of data of consecutive patients with chronic hypoparathyroidism was performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Interactions between the collected variables were represented in a correlation matrix. The association of variables with serum calcium concentration was tested by multivariable linear regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Data from 101 patients with hypoparathyroidism were collected. Their initial characteristics were consistent with the literature. Tubular calcium reabsorption corrected by glomerular filtration rate (TRCa\/GFR), fasting calcium-to-creatinine ratio (UCa\/UCr) and alfacalcidol dose were independently associated with serum ionized calcium concentration. TRCa\/GFR was the most important explanatory variable, followed by UCa\/UCr. Alfacalcidol dose was the only modifiable variable independently associated with TRCa\/GFR and UCa\/UCr. Longitudinal analysis of 33 patients showed that the increase in ionized calcium concentration due to a higher dose of alfacalcidol was mostly associated with an increase in TRCa\/GFR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The main determinant of blood calcium levels in patients with chronic hypoparathyroidism is tubular calcium reabsorption, assessed by TRCa\/GFR. Alfacalcidol is effective in correcting hypocalcemia due to its tubular effect but may lead to renal complications due to its intestinal and bone effects. The use of complementary treatment with thiazide diuretics or PTH analogs, possibly guided by the calculation of TRCa\/GFR, could allow a better correction of hypocalcemia in these patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejendo\/lvag036","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T12:48:05Z","timestamp":1771418885000},"page":"326-335","source":"Crossref","is-referenced-by-count":0,"title":["Determinants of extracellular fluid calcium concentration in patients with chronic hypoparathyroidism"],"prefix":"10.1093","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8678-3733","authenticated-orcid":false,"given":"Arthur","family":"Michon-Colin","sequence":"first","affiliation":[{"name":"Service de Physiologie, Unit\u00e9 d\u2019Explorations Fonctionnelles M\u00e9taboliques et R\u00e9nales, H\u00f4pital Europ\u00e9en Georges-Pompidou, Assistance Publique\u2014H\u00f4pitaux de Paris , Paris ,","place":["France"]},{"name":"Universit\u00e9 Paris Cit\u00e9 (UPC) , Paris ,","place":["France"]},{"name":"Centre de R\u00e9f\u00e9rence des Maladies R\u00e9nales H\u00e9r\u00e9ditaires de L'Enfant et de L'Adulte (MARHEA) , Paris 75015 ,","place":["France"]},{"name":"Centre de R\u00e9f\u00e9rence des Maladies Rares du Calcium et du Phosphate , Paris 75015 ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Th\u00e9au","family":"Blanchard","sequence":"additional","affiliation":[{"name":"INRIA, INSERM, HeKA , Paris F-75015 ,","place":["France"]},{"name":"GE Healthcare , Buc F-78530 ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elise","family":"Bouderlique","sequence":"additional","affiliation":[{"name":"Service de Physiologie, Unit\u00e9 d\u2019Explorations Fonctionnelles M\u00e9taboliques et R\u00e9nales, H\u00f4pital Europ\u00e9en Georges-Pompidou, Assistance Publique\u2014H\u00f4pitaux de Paris , Paris ,","place":["France"]},{"name":"Universit\u00e9 Paris Cit\u00e9 (UPC) , Paris ,","place":["France"]},{"name":"Centre de R\u00e9f\u00e9rence des Maladies R\u00e9nales H\u00e9r\u00e9ditaires de L'Enfant et de L'Adulte (MARHEA) , Paris 75015 ,","place":["France"]},{"name":"Centre de R\u00e9f\u00e9rence des Maladies Rares du Calcium et du Phosphate , Paris 75015 ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9rard","family":"Maruani","sequence":"additional","affiliation":[{"name":"Service de Physiologie, Unit\u00e9 d\u2019Explorations Fonctionnelles M\u00e9taboliques et R\u00e9nales, H\u00f4pital Europ\u00e9en Georges-Pompidou, Assistance Publique\u2014H\u00f4pitaux de Paris , Paris ,","place":["France"]},{"name":"Centre de R\u00e9f\u00e9rence des Maladies R\u00e9nales H\u00e9r\u00e9ditaires de L'Enfant et de L'Adulte (MARHEA) , Paris 75015 ,","place":["France"]},{"name":"Centre de R\u00e9f\u00e9rence des Maladies Rares du Calcium et du Phosphate , Paris 75015 ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4953-6917","authenticated-orcid":false,"given":"Pascal","family":"Houillier","sequence":"additional","affiliation":[{"name":"Service de Physiologie, Unit\u00e9 d\u2019Explorations Fonctionnelles M\u00e9taboliques et R\u00e9nales, H\u00f4pital Europ\u00e9en Georges-Pompidou, Assistance Publique\u2014H\u00f4pitaux de Paris , Paris ,","place":["France"]},{"name":"Universit\u00e9 Paris Cit\u00e9 (UPC) , Paris ,","place":["France"]},{"name":"Centre de R\u00e9f\u00e9rence des Maladies R\u00e9nales H\u00e9r\u00e9ditaires de L'Enfant et de L'Adulte (MARHEA) , Paris 75015 ,","place":["France"]},{"name":"Centre de R\u00e9f\u00e9rence des Maladies Rares du Calcium et du Phosphate , Paris 75015 ,","place":["France"]},{"name":"Centre de Recherche des Cordeliers, INSERM, Sorbonne Universit\u00e9, Universit\u00e9 Paris Cit\u00e9 , Paris 75006 ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"issue":"5","key":"2026033105164452600_lvag036-B1","doi-asserted-by":"publisher","first-page":"F1047","DOI":"10.1152\/ajprenal.00230.2016","article-title":"A model of calcium homeostasis in the rat","volume":"311","author":"Granjon","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5 Pt 2","key":"2026033105164452600_lvag036-B2","doi-asserted-by":"publisher","first-page":"F707","DOI":"10.1152\/ajprenal.1989.257.5.F707","article-title":"Renal calcium transport: mechanisms and regulation\u2013an overview","volume":"257","author":"Bronner","year":"1989","journal-title":"Am J Physiol"},{"issue":"1","key":"2026033105164452600_lvag036-B3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1365-2265.1978.tb01350.x","article-title":"Diagnostic procedures in disorders of calcium metabolism","volume":"8","author":"Nordin","year":"1978","journal-title":"Clin Endocrinol"},{"key":"2026033105164452600_lvag036-B4","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1056\/NEJMcp1800213","article-title":"Hypoparathyroidism","volume":"380","author":"Gafni","year":"2019","journal-title":"N Engl J Med."},{"issue":"2","key":"2026033105164452600_lvag036-B5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/00005792-197603000-00001","article-title":"The spectrum of the hypoparathyroid states: a classification based on physiologic principles","volume":"55","author":"Nusynowitz","year":"1976","journal-title":"Medicine."},{"issue":"7591)","key":"2026033105164452600_lvag036-B6","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/S0140-6736(69)91353-1","article-title":"Relation between serum and urinary calcium with particular reference to parathyroid activity","volume":"293","author":"Peacock","year":"1969","journal-title":"Lancet"},{"issue":"2","key":"2026033105164452600_lvag036-B7","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-15-0628","article-title":"European Society of Endocrinology clinical guideline: treatment of chronic hypoparathyroidism in adults","volume":"173","author":"Bollerslev","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2026033105164452600_lvag036-B8","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1210\/jc.2015-3907","article-title":"Management of hypoparathyroidism: summary statement and guidelines","volume":"101","author":"Brandi","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026033105164452600_lvag036-B9","doi-asserted-by":"publisher","first-page":"R33","DOI":"10.1530\/EJE-21-1044","article-title":"European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE educational program of parathyroid disorders","volume":"186","author":"Bollerslev","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2026033105164452600_lvag036-B10","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.1210\/jc.2015-2257","article-title":"The impact of hypoparathyroidism treatment on the kidney in children: long-term retrospective follow-up study","volume":"100","author":"Levy","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2026033105164452600_lvag036-B11","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.1210\/jc.2012-1808","article-title":"Long-term follow-up of patients with hypoparathyroidism","volume":"97","author":"Mitchell","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2026033105164452600_lvag036-B12","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1056\/NEJM197803162981101","article-title":"Treatment of hypoparathyroid patients with chlorthalidone","volume":"298","author":"Porter","year":"1978","journal-title":"N Engl J Med"},{"issue":"12","key":"2026033105164452600_lvag036-B13","doi-asserted-by":"publisher","first-page":"ziaf174","DOI":"10.1093\/jbmrpl\/ziaf174","article-title":"Hydrochlorothiazide with salt restriction in nonsurgical hypoparathyroidism: a placebo-controlled single-blinded randomized crossover trial assessing efficacy and safety","volume":"9","author":"Jha","year":"2025","journal-title":"JBMR Plus"},{"key":"2026033105164452600_lvag036-B14","volume-title":"StatPearls","author":"Herman","year":"2021"},{"issue":"4","key":"2026033105164452600_lvag036-B15","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1210\/clinem\/dgae693","article-title":"Efficacy and safety of TransCon PTH in adults with hypoparathyroidism: 52-week results from the phase 3 PaTHway trial","volume":"110","author":"Clarke","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026033105164452600_lvag036-B16","first-page":"99","article-title":"Evaluation of the calcium content of diet by frequential self-questionnaire","volume":"58","author":"Fardellone","year":"1991","journal-title":"Rev Rhum Mal Osteoartic"},{"issue":"2","key":"2026033105164452600_lvag036-B17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1136\/gut.39.2.273","article-title":"Oral calcium tolerance test in the early diagnosis of primary hyperparathyroidism and multiple endocrine neoplasia type 1 in patients with the Zollinger-Ellison syndrome. Groupe de Recherche et d\u2019Etude du Syndrome de Zollinger-Ellison","volume":"39","author":"Cadiot","year":"1996","journal-title":"Gut"},{"issue":"3","key":"2026033105164452600_lvag036-B18","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1365-2265.1980.tb02704.x","article-title":"Primary hyperparathyroidism with intermittent hypercalcaemia: serial observations and simple diagnosis by means of an oral calcium tolerance test","volume":"12","author":"Broadus","year":"1980","journal-title":"Clin Endocrinol"},{"issue":"7929","key":"2026033105164452600_lvag036-B19","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0140-6736(75)92736-1","article-title":"Nomogram for derivation of renal threshold phosphate concentration","volume":"2","author":"Walton","year":"1975","journal-title":"Lancet"},{"issue":"10","key":"2026033105164452600_lvag036-B20","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.1210\/jc.2002-021404","article-title":"Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone","volume":"88","author":"Maruani","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"key":"2026033105164452600_lvag036-B21","volume-title":"A Language and Environment for Statistical Computing: Reference index","author":"R Development Core Team","year":"2010"},{"issue":"4","key":"2026033105164452600_lvag036-B22","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1198\/000313002533","article-title":"Corrgrams: exploratory displays for correlation matrices","volume":"56","author":"Friendly","year":"2002","journal-title":"Am Stat."},{"issue":"3","key":"2026033105164452600_lvag036-B23","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v045.i03","article-title":"Mice: multivariate imputation by chained equations in R","volume":"45","author":"Buuren S van","year":"2011","journal-title":"J Stat Soft"},{"issue":"10","key":"2026033105164452600_lvag036-B24","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1002\/jbmr.483","article-title":"Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research","volume":"26","author":"Bilezikian","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2026033105164452600_lvag036-B25","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1210\/jc.2015-3908","article-title":"Epidemiology and diagnosis of hypoparathyroidism","volume":"101","author":"Clarke","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2026033105164452600_lvag036-B26","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1359\/jbmr.080803","article-title":"Dynamic and structural properties of the skeleton in hypoparathyroidism","volume":"23","author":"Rubin","year":"2008","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2026033105164452600_lvag036-B27","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1146\/annurev.med.051308.111339","article-title":"Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23","volume":"61","author":"Bergwitz","year":"2010","journal-title":"Annu Rev Med"},{"issue":"3","key":"2026033105164452600_lvag036-B28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/embj.201284188","article-title":"FGF23 promotes renal calcium reabsorption through the TRPV5 channel","volume":"33","author":"Andrukhova","year":"2014","journal-title":"EMBO J"},{"issue":"6","key":"2026033105164452600_lvag036-B29","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1152\/ajplegacy.1974.226.6.1490","article-title":"Renal actions of vitamin D in D-deficient rats","volume":"226","author":"Costanzo","year":"1974","journal-title":"Am J Physiol"},{"issue":"4","key":"2026033105164452600_lvag036-B30","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S2213-8587(13)70106-2","article-title":"Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study","volume":"1","author":"Mannstadt","year":"2013","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvag036\/66992690\/lvag036.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/194\/3\/326\/66992690\/lvag036.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/194\/3\/326\/66992690\/lvag036.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T09:16:48Z","timestamp":1774948608000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/194\/3\/326\/8490649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvag036","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2026,2,19]]}}}